DarioHealth Corp.

NASDAQ:DRIO

Medical - Diagnostics & Research

Healthcare
$5.13 -1.68%

-$0.12 today

Market cap
$50.27M
Beta
1.08
P/E (TTM)
5.5
EPS (TTM)
$1.26
52W Low $5.94High $17.74

Volume 0.01M

Average 0.01M

DRIO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

DarioHealth Corp.NASDAQ: DRIO

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin holds steady near 57.3%

Gross margin was 57.3% in Q1 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 56.5%, down 9.7 pp year over year. Over 3 fiscal years it widened by 21.7 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.3%+12.0 pp QoQ
Last fiscal yearDec 2025
56.6%+7.6 pp YoY
LTMMar 2026
56.5%-9.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.2 pp——
1 year+7.6 pp——
3 years+21.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
56.6%
Year-over-year change
+7.6pp

Gross Margin vs competitors

How DRIO compares with its peers on the latest reported figures

  • DRIO's LTM Mar 2026 gross margin of 56.5% is the 5th highest of the 11 companies compared; the peer median is 43.6%.
  • Its year-over-year change of -9.7 pp is the 8th highest of 11, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +21.7 pp compares with a peer median of -3.2 pp.
DRIO Competitors Peer median
Gross Margin for DRIO and competitors
Company Period LTM level YoY 3-year change
NNNNAnbio Biotechnology Class A Ordinary SharesFY202587.2% +15.3 pp+33.9 pp
VSTMVerastem, Inc.LTM Mar 202683.7% -16.3 pp-17.1 pp
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
DRIODarioHealth Corp.LTM Mar 202656.5% -9.7 pp+21.7 pp
AVNSAvanos Medical, Inc.LTM Mar 202648.6% -6.2 pp-7.9 pp
FLGTFulgent Genetics, Inc.LTM Mar 202638.7% -0.1 pp-18.7 pp
PACBPacific Biosciences of California, Inc.LTM Mar 202637.1% +20.9 pp-6.5 pp
INNVInnovAge Holding Corp.LTM Mar 202620.7% +2.8 pp+49.1 pp
RGNXREGENXBIO Inc.LTM Mar 2026-0.1% -76.7 pp+36.5 pp
ABSIAbsci CorporationLTM Mar 2026-1316.9% -337.8 pp+605.7 pp
Peer median (excluding DRIO) 43.6%-0.1 pp-3.2 pp

Competitors are the stored peer set for DRIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue20.51M27.66M20.35M27.04M22.36M
Cost of Revenue12.44M18M14.37M13.77M9.69M
Gross Profit8.07M9.66M5.98M13.27M12.67M
Gross Margin39.3%34.9%29.4%49.1%56.6%
Research & Development17.22M19.65M20.25M24.18M13.79M
Selling, General & Admin62.36M46.82M41.8M46.83M35.53M
Operating Expenses84.56M66.47M62.17M71.01M49.32M
Depreciation & Amortization4.46M4.72M4.99M7.43M3.56M
EBITDA(70.02M)(55.6M)(54.38M)(37.08M)(34.69M)
EBITDA Margin-341.3%-201.0%-267.2%-137.1%-155.2%
Operating Income(76.49M)(56.81M)(56.19M)(57.74M)(36.66M)
Operating Margin-372.9%-205.4%-276.1%-213.6%-163.9%
Interest Income44K506K1.87M1.12M943K
Interest Expense84K2.68M645K96K3.36M
Other Income / Expenses(235K)(5.38M)(3.17M)13.15M(4.95M)
Income Before Tax(76.73M)(62.19M)(59.36M)(44.6M)(41.61M)
Pre-Tax Margin-374.1%-224.9%-291.7%-164.9%-186.1%
Income Tax Expense32K4K64K(1.85M)105K
Net Income(76.76M)(62.19M)(59.43M)(42.75M)(41.71M)
Net Margin-374.2%-224.9%-292.0%-158.1%-186.6%
EPS (Basic)(4.63)(2.63)(1.93)(0.74)1.24
EPS (Diluted)(4.63)(2.63)(1.93)(0.74)1.24
Weighted Avg Shares16.59M23.64M28.37M40.42M49.63M
Weighted Avg Shares (Diluted)16.59M23.64M28.37M40.42M49.63M

DarioHealth Corp.

NASDAQ:DRIO

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.